Biotech Stock Crashes 60% After CEO Bets the Farm on Dogecoin Mining Pivot
Wall Street’s latest ’innovation’ play: a cancer research firm dumping its pipeline to chase meme-coin profits. Traders aren’t buying it—literally.
The move follows a pattern of desperate pivots by microcap firms, though few have dared to swap petri dishes for crypto rigs. Analysts note the company’s new ’mining division’ consists of three gaming PCs in a repurposed lab freezer.
Meanwhile in crypto-land, Dogecoin whales shrug—another day, another bagholder. The coin’s 90% crash from its 2021 ATH apparently looks like a ’buying opportunity’ to biotech execs with expired options.